Position in ARGX
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$209,861,574
+$36,450,567 QoQ
Shares Held
226,200
-4.7% QoQ
Ownership
0.364%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#20
of 504 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 87%
Shared 0%
None 13%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JENNISON ASSOCIATES LLC holds $3,761,825,691 across 45 Biotechnology names. ARGX ranks #2 (5.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,998,530 | $1,489,459,806 | |
| 2 | ARGX |
Argenx SE
This page
|
226,200 | $209,861,574 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
4,481,964 | $158,616,705 | |
| 4 | PVLA |
Palvella Therapeutics, Inc.
|
960,619 | $146,801,794 | |
| 5 | PTGX |
Protagonist Therapeutics, Inc
|
1,151,681 | $141,173,056 | |
| 6 | SRRK |
Scholar Rock Holding Corp
|
2,358,587 | $129,722,285 | |
| 7 | IMVT |
Immunovant, Inc.
|
3,310,238 | $127,543,470 | |
| 8 | ARQT |
Arcutis Biotherapeutics, Inc.
|
4,219,058 | $110,623,700 |
All Filings in ARGX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $209,861,574 | 226,200 | Shares | Defined | 2026-08-03 | |
| 2026-03-31 | $173,411,007 | 237,468 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $193,217,512 | 229,761 | Shares | Defined | 2026-01-30 | |
| 2025-09-30 | $177,182,563 | 240,228 | Shares | Defined | 2025-10-30 | |
| 2025-06-30 | $145,878,719 | 264,647 | Shares | Defined | 2025-08-01 | |
| 2025-03-31 | $147,647,234 | 249,461 | Shares | Defined | 2025-05-05 | |
| 2024-12-31 | $185,821,635 | 302,149 | Shares | Defined | 2025-01-24 | |
| 2024-09-30 | $128,996,609 | 237,966 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $101,677,797 | 236,438 | Shares | Defined | 2024-08-05 | |
| 2024-03-31 | $91,900,941 | 233,417 | Shares | Defined | 2024-05-02 | |
| 2023-12-31 | $102,034,369 | 268,208 | Shares | Defined | 2024-02-01 | |
| 2023-09-30 | $743,219,193 | 1,511,745 | Shares | Defined | 2023-10-31 | |
| 2023-06-30 | $445,608,707 | 1,143,378 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $423,983,372 | 1,137,966 | Shares | Defined | 2023-04-26 | |
| 2022-12-31 | $561,763,975 | 1,482,892 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $546,897,398 | 1,549,065 | Shares | Defined | 2022-11-01 | |
| 2022-06-30 | $585,455,605 | 1,545,227 | Shares | Defined | 2022-08-02 | |
| 2022-03-31 | $320,801,123 | 1,017,415 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $288,756,518 | 824,571 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $251,307,790 | 832,145 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $226,210,449 | 751,355 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $198,229,852 | 719,815 | Shares | Defined | 2021-05-11 | |
| 2020-12-31 | $122,819,924 | 417,627 | Shares | Defined | 2021-02-05 | |
| 2020-09-30 | $112,191,859 | 427,365 | Shares | Defined | 2020-11-04 | |
| 2020-06-30 | $102,130,543 | 453,450 | Shares | Defined | 2020-08-06 | |
| 2020-03-31 | $53,576,962 | 406,718 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||